Fatemeh Naeini

Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial

Zahra Namkhah, Fatemeh Naeini, Seyed Mahdi Rezayat et al. · International Journal of Clinical Practice · 2021 · 59 citations

Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status

Arash Karimi, Fatemeh Naeini, Hamid Reza Niazkar et al. · Food & Function · 2022 · 50 citations

Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study

Helda Tutunchi, Fatemeh Naeini, Majid Mobasseri et al. · Clinical Nutrition ESPEN · 2021 · 38 citations

Metabolic Syndrome, Liver Fibrosis, Hepatology +11

Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial

Fatemeh Naeini, Zahra Namkhah, Helda Tutunchi et al. · European Journal of Gastroenterology & Hepatology · 2021 · 38 citations

Randomized Clinical Trial, Pharmacotherapy, Fatty Liver Disease +19

Serum neuregulin 4 (NRG‐4) level and non‐alcoholic fatty liver disease (NAFLD): A case‐control study

Helda Tutunchi, Majid Mobasseri, Naser Aghamohammadzadeh et al. · International Journal of Clinical Practice · 2021 · 35 citations